| Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ... Science 348 (6230), 124-128, 2015 | 8129 | 2015 |
| The cancer genome atlas pan-cancer analysis project JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ... Nature genetics 45 (10), 1113-1120, 2013 | 6580 | 2013 |
| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2708 | 2015 |
| Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis MM Jesper V Olsen, Michiel Vermeulen, Anna Santamaria, Chanchal Kumar ... Science Signaling, 2010 | 1704 | 2010 |
| Emerging landscape of oncogenic signatures across human cancers G Ciriello, ML Miller, BA Aksoy, Y Senbabaoglu, N Schultz, C Sander Nature genetics 45 (10), 1127-1133, 2013 | 1509 | 2013 |
| Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs AA Khan, D Betel, ML Miller, C Sander, CS Leslie, DS Marks Nature biotechnology 27 (6), 549-555, 2009 | 655 | 2009 |
| Linear motif atlas for phosphorylation-dependent signaling. ML Miller, LJ Jensen, F Diella, C Jørgensen, M Tinti, L Li, M Hsiung, ... Science signaling 1 (35), ra2, 2008 | 527 | 2008 |
| Mitochondrial DNA copy number variation across human cancers E Reznik, ML Miller, Y Şenbabaoğlu, N Riaz, J Sarungbam, SK Tickoo, ... elife 5, e10769, 2016 | 455 | 2016 |
| Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient A Jiménez-Sánchez, D Memon, S Pourpe, H Veeraraghavan, Y Li, ... Cell 170 (5), 927-938. e20, 2017 | 449 | 2017 |
| KinomeXplorer: an integrated platform for kinome biology studies H Horn, EM Schoof, J Kim, X Robin, ML Miller, F Diella, A Palma, ... Nature methods 11 (6), 603-604, 2014 | 356 | 2014 |
| UVB-induced tumor heterogeneity diminishes immune response in melanoma Y Wolf, O Bartok, S Patkar, GB Eli, S Cohen, K Litchfield, R Levy, ... Cell 179 (1), 219-235. e21, 2019 | 333 | 2019 |
| Promises and challenges of adoptive T-cell therapies for solid tumours M Morotti, A Albukhari, A Alsaadi, M Artibani, JD Brenton, SM Curbishley, ... British journal of cancer 124 (11), 1759-1776, 2021 | 176 | 2021 |
| Perturbation biology: inferring signaling networks in cellular systems EJ Molinelli, A Korkut, W Wang, ML Miller, NP Gauthier, X Jing, P Kaushik, ... PLoS computational biology 9 (12), e1003290, 2013 | 164 | 2013 |
| Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy A Jiménez-Sánchez, P Cybulska, KLV Mager, S Koplev, O Cast, ... Nature Genetics 52 (6), 582-593, 2020 | 161 | 2020 |
| NetPhosYeast: prediction of protein phosphorylation sites in yeast CR Ingrell, ML Miller, ON Jensen, N Blom Bioinformatics 23 (7), 895-897, 2007 | 160 | 2007 |
| Comprehensive benchmarking and integration of tumor microenvironment cell estimation methods A Jiménez-Sánchez, O Cast, ML Miller Cancer Research 79 (24), 6238-6246, 2019 | 136 | 2019 |
| The SH2 domain interaction landscape M Tinti, L Kiemer, S Costa, ML Miller, F Sacco, JV Olsen, M Carducci, ... Cell reports 3 (4), 1293-1305, 2013 | 128 | 2013 |
| Pan-cancer analysis of mutation hotspots in protein domains ML Miller, E Reznik, NP Gauthier, BA Aksoy, A Korkut, J Gao, G Ciriello, ... Cell systems 1 (3), 197-209, 2015 | 118 | 2015 |
| Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets ML Miller, EJ Molinelli, JS Nair, T Sheikh, R Samy, X Jing, Q He, A Korkut, ... Science signaling 6 (294), ra85-ra85, 2013 | 98 | 2013 |
| NetPhosBac–a predictor for Ser/Thr phosphorylation sites in bacterial proteins ML Miller, B Soufi, C Jers, N Blom, B Macek, I Mijakovic Proteomics 9 (1), 116-125, 2009 | 84 | 2009 |
Chris SanderHarvard Medical School, Broad Institute, Dana-Farber Cancer Institute, Memorial Sloan Kettering在 sanderlab.org 的电子邮件经过验证
